Table 1 Anthropometric and clinical features of the individuals from the two families with mutations in NPPC

From: Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature

NPPC genotype

Family member

Height in cm (SDS)

Weight in kg (SDS)

Arm span (cm)

Arm span: height

Sitting height (cm)

Sitting height: height

Hand length in cm (SDS)

Other clinical features

Family 1: p.Arg117Gly

 Heterozygous

Proband (III.1) (13.5 years, Tanner 5)

144.7 (–2.3)

54.5 (+0.2)

142.4

0.984

79.0

0.546

16.5 (–3.7)

Small hands and feet, short fourth metacarpal, cubitus and genu valgus, lower-limb hypertrophy, and hypertelorism

 Heterozygous

Mother (II.5)

148.6 (–2.6)

64 (+0.8)

144.4

0.971

80.0

0.539

16.0 (–4.5)

Small hands and feet

 Wild type

Father (II.4)

164.3 (–2.0)

90 (+1.4)

172.0

1.046

87.5

0.533

19.0 (–1.1)

Hypertelorism, burly aspect

 Wild type

Sister (III.2) (11.5 years, Tanner 3)

147.0 (–0.4)

52.5 (+1.0)

145.5

0.990

76.3

0.524

15.5 (–1.4)

 

 Wild type

Maternal grandfather (I.3)

146.5a (–4.8)

58 (–1.5)

156.0

1.065

81.0

0.553

15.0b (–4.2)

Arthritis

 Heterozygous

Maternal grandmother (I.4)

138.5a (–4.3)

57 (–0.1)

144.0

1.040

71.0

0.513

15.5 (–5.2)

Small hands

 Heterozygous

Maternal Aunt (II.6)

146.5 (–2.9)

50 (–0.9)

149.0

1.017

79.0

0.539

15.0 (–6.0)

Small hands

Family 2: p.Gly119Cys

 Wild type

Proband (II.2) (17.2 years, Tanner 4)

160.5c (–2.1)

47.5 (–2.9)

161.5

1.022

78.5

0.496

18.4 (–1.3)

Delayed puberty

 Heterozygous

Sister (II.1)

145.0 (–2.9)

40 (3.0)

145.8

1.006

75.0

0.517

17.2 (–2.1)

Small hands

 Heterozygous

Father (I.1)

158.8 (–2.4)

65.9 (–0.4)

153.3

0.965

81.0

0.510

17,7 (–2.1)

Small hands

 Wild type

Mother (I.2)

157.5 (–0.8)

72 (+1.1)

156.0

0.990

79

0.502

17.9 (–1.6)

 
  1. SDS values are according to age and sex for the national standards. Family 1 was Spanish, while family 2 was Brazilian. All patients and their family members had proportionate growth. Children’s ages and Tanner stages are indicated.
  2. aAge influenced height loss, thus ratios must be taken with precaution.
  3. bHand length is inaccurate due to arthritis.
  4. cThe patient is still growing and has been diagnosed with constitutional delay of growth and puberty. He started puberty after a short-term treatment with testosterone cypionate (50 mg per month for 3 months) at the age of 14.9 years.